APOSAN Dr. Künzer has been sold to IK Investment Partners

APOSAN Dr. Künzer GmbH, a leading pharmaceutical homecare company in Germany, founded in 1991 by Dr. Clemens Künzer is sold to IK Investment Partners. Financial terms of the transaction were not disclosed.

APOSAN, headquartered in Cologne, serves over 10,000 homecare patients per year through the compounding of individualized, sterile infusible and injectable medication for outpatient treatment. The company is an integrated full-range pharmaceutical homecare supplier with its own GMP manufacturing capacities and a dedicated key account management and homecare nurses team to generate and support its growing nationwide patient base. APOSAN is a market leader in the field of intravenous antibiotic therapies. Furthermore, the company also offers the production of patient-individual parenteral nutrition and prescription drugs in sterile ready-to-use syringes used for ophthalmic surgeries.

“APOSAN has attractive growth opportunities, targeting niches within the German homecare market, and a highly experienced and committed management team. We look forward to support APOSAN over the coming years,” says Anders Petersson, Partner at IK Investment Partners, and advisor to the IK Small Cap I Fund.

“Lincoln’s senior-level attention, thoughtful advice and continuous commitment throughout the entire sale process were unsurpassed. Especially Lincoln’s in-depth healthcare know-how and transaction expertise allowed them to convey our unique value drivers and competitive advantages to potential acquirers, which was critical in making this a successful transaction. I am very happy with the quality of the advice of Lincoln during the process” says Dr. Clemens Künzer, founder of APOSAN.

IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK funds have raised more than Euro 7.5 billion of capital and invested in over 100 European companies. For more information, visit www.ikinvest.com.

Lincoln International acted as the exclusive financial advisor to the sole owner Dr. Clemens Künzer and supported APOSAN Dr. Künzer GmbH and the management team throughout the process. This included providing advisory expertise and managing the preparatory, marketing, due diligence and negotiation phase of the transaction. Lincoln International’s Global Healthcare Team regularly advises owners and companies in the healthcare sector and has deep expertise in the pharmaceutical and homecare market environments.

Share: